tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Christopher James, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).
Analyst Christopher James, currently employed carries an average stock price target met ratio of 40% that have a potential upside of 32.05% achieved within 75 days. Previously, Christopher James worked at LADENBURG, B. RILEY.
Christopher James’s has documented 30 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ACHN, Achillion Pharmaceuticals at 12-Sep-2017.
Analyst best performing recommendations are on CORT (CORCEPT THERAPEUTICS ORPORATED).
The best stock recommendation documented was for CORT (CORCEPT THERAPEUTICS ORPORATED) at 7/18/2017. The price target of $20 was fulfilled within 79 days with a profit of $7.59 (61.16%) receiving and performance score of 7.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$2
$1.82 (1011.11%)
$5
5 years 7 months ago
(03-May-2019)
2/3 (66.67%)
$-0.96 (-32.43%)
528
Hold
$4
6 years 9 months 25 days ago
(08-Feb-2018)
4/4 (100%)
$-0.81 (-16.84%)
106
Buy
$5
$4.82 (2677.78%)
$6
6 years 11 months 22 days ago
(11-Dec-2017)
0/4 (0%)
$2.14 (74.83%)
Buy
$10
7 years 2 months 21 days ago
(12-Sep-2017)
0/2 (0%)
$5.79 (137.53%)
Hold
$4
$3.82 (2122.22%)
$5
7 years 2 months 22 days ago
(11-Sep-2017)
6/7 (85.71%)
$0.17 (4.44%)
49
What Year was the first public recommendation made by Christopher James?
